The death-domain fold of the ASC PYRIN domain, presenting a basis for PYRIN/PYRIN recognition

Journal of Molecular Biology

Volumn 332, Issue 5, 2003, Pages 1155-1163

  Liepinsh, Edvards ^a   Barbals, Raitis ^b   Dahl, Edgar ^c   Sharipo, Anatoly ^b   Staub, Eike ^c   Otting, Gottfried ^a,d  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF LATVIA   (Latvia)

^c metaGen Pharmaceuticals GmbH   (Germany)

^d AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

Author keywords

Death domain superfamily; Human ASC; NMR spectroscopy; PYRIN domain; Three dimensional protein structure

Indexed keywords

CASPASE; PROTEIN;

AMINO ACID SEQUENCE; APOPTOSIS; ARTICLE; COMPARATIVE STUDY; DNA HELIX; ELECTRIC ACTIVITY; ENZYME ACTIVATION; INFLAMMATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE;

DANIO RERIO;

EID: 0042386425     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2003.07.007     Document Type: Article

References (54)

1. Huang B.H., Eberstadt M., Olejniczak E.T., Meadows R.P., Fesik S.W. NMR structure and mutagenesis of the Fas (Apo-1/CD95) death domain. Nature. 384:1996;638-641.
2. Eberstadt M., Huang B., Chen Z., Meadows R.P., Ng S., Zheng L., et al. NMR structure and mutagenesis of the FADD (Mort1) death-effector domain. Solution structure of the RAIDD CARD and model for CARD/CARD interaction in caspase-2 and caspase-9 recruitment. Nature. 392:1998;941-945.
3. Chou J.J., Matsuo H., Duan H., Wagner G. Solution structure of the RAIDD CARD and model for CARD/CARD interaction in caspase-2 and caspase-9 recruitment. Cell. 94:1998;171-180.
4. Weber C.H., Vincenz C. The death domain superfamily: a tale of two interfaces? Trends Biochem. Sci. 26:2001;475-481.
5. Liepinsh E., Ilag L.L., Otting G., Ibáñez C.F. NMR structure of the death domain of the p75 neurotrophin receptor. EMBO J. 16:1997;4999-5005.
6. Xiao T., Towb P., Wasserman S.A., Sprang S.R. Three-dimensional structure of a complex between the death domains of Pelle and Tube. Cell. 99:1999;545-555.
7. Jeong E.J., Bang S., Lee T.H., Park Y.I., Sim W.S., Kim K.S. The solution structure of FADD death domain - structural basis of death domain interactions of Fas and FADD. J. Biol. Chem. 274:1999;16337-16342.
8. Berglund H., Olerenshaw D., Sankar A., Federwisch M., McDonald N.Q., Driscoll P.C. The three-dimensional solution structure and dynamic properties of the human FADD death domain. J. Mol. Biol. 302:2000;171-188.
9. Sukits S.F., Lin L., Hsu S., Malakian K., Powers R., Xu G. Solution structure of the tumor necrosis factor receptor-1 death domain. J. Mol. Biol. 310:2001;895-906.
10. Hill J.M., Vaidyanathan H., Ramos J.W., Ginsberg M.H., Werner M.H. Recognition of ERK MAP kinase by PEA-15 reveals a common docking site within the death domain and death effector domain. EMBO J. 21:2002;6494-6504.
11. Day C.L., Dupont C., Lackmann M., Vaux D.L., Hinds M.G. Solution structure and mutagenesis of the caspase recruitment domain (CARD) from Apaf-1. Cell Death Differ. 6:1999;1125-1132.
12. Qin H., Srinivasula S.M., Wu G., Fernandes-Alnemri T., Alnemri E.S., Shi Y. Structural basis of procaspase-9 recruitment by the apoptotic protease-activating factor 1. Nature. 399:1999;549-557.
13. Zhou P., Chou J., Olea R.S., Yuan J., Wagner G. Solution structure of Apaf-1 CARD and its interactino with caspase-9 CARD; a structural basis for specific adaptor/caspase interaction. Proc. Natl Acad. Sci. USA. 96:1999;11265-11270.
14. Humke E.W., Shriver S.K., Starovasnik M.A., Fairbrother W.J., Dixit V.M. ICEBERG: a novel inhibitor of interleukin-1β generation. Cell. 103:2000;99-111.
15. Staub E., Dahl E., Rosenthal A. The DAPIN family: a novel domain links apoptotic and interferon response proteins. Trends Biochem. Sci. 26:2001;83-85.
16. Martinon F., Hofmann K., Tschopp J. The PYRIN domain: a possible member of the death domain-fold family implicated in apoptosis and inflammation. Curr. Biol. 11:2001;R118-R120.
17. Fairbrother W.J., Gordon N.C., Humke E.W., O'Rourke K.M., Starovasnik M.A., Yin J.P., Dixit V.M. The PYRIN domain: a member of the death domain-fold superfamily. Protein Sci. 10:2001;1911-1918.
18. Pawlowski K., Pio F., Chu Z., Reed J.C., Godzik A. PAAD - a new protein domain associated with apoptosis, cancer and autoimmune diseases. Trends Biochem. Sci. 26:2001;85-87.
19. Richards N., Schaner P., Diaz A., Stuckey J., Shelden E., Wadhwa A., Gumucio D.L. Interaction between PYRIN and the apoptotic speck protein (ASC) modulates ASC-induced apoptosis. J. Biol. Chem. 276:2001;39320-39329.
20. Aravind L., Dixit V.M., Koonin E.V. Apoptotic molecular machinery: vastly increased complexity in vertebrates revealed by genome comparisons. Science. 291:2001;1279-1284.
21. Bertin J., DiStefano P.S. The PYRIN domain: a novel motif found in apoptosis and inflammation proteins. Cell Death Differ. 7:2000;1273-1274.
22. Gumucio D.L., Diaz A., Schaner P., Richards N., Babcock C., Schaller M., Cesena T. Fire and ICE: the role of PYRIN domain-containing proteins in inflammation and apoptosis. Clin. Exptl. Rheum. 20:2002;S45-S53.
23. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial mediterranean fever. Cell. 90:1997;797-807.
24. Masumoto J., Taniguchi S., Ayukawa K., Sarvotham H., Kishino T., Niikawa N., et al. ASC, a novel 22-kDa protein, aggregates during apoptosis of human promyelocytic leukemia HL-60 cells. J. Biol. Chem. 274:1999;33835-33838.
25. Shiohara M., Taniguchi S., Masumoto J., Yasui K., Koike K., Komiyama A., Sagara J. ASC, which is composed of a PYD and a CARD, is up-regulated by inflammation and apoptosis in human neutrophils. Biochem. Biophys. Res. Commun. 293:2002;1314-1318.
26. Stehlik C., Fiorentino L., Dorfleutner A., Bruey J.M., Ariza E.M., Sagara J., Reed J.C. The PAAD/PYRIN-family protein ASC is a dual regulator of a conserved step in nuclear factor κB activation pathways. J. Exptl. Med. 196:2002;1605-1615.
27. Masumoto J., Taniguchi S., Sagara J. PYRIN N-terminal homology domain- and caspase recruitment domain-dependent oligomerization of ASC. Biochem. Biophys. Res. Commun. 280:2001;652-655.
28. Masumoto J., Taniguchi S., Nakayama J., Shiohara M., Hidaka E., Katsuyama T., et al. Expression of apoptosis-associated speck-like protein containing a caspase recruitment domain, a PYRIN N-terminal homology domain-containing protein, in normal human tissues. J. Histochem. Cytochem. 49:2001;1269-1275.
29. Srinivasula S.M., Poyet J.L., Razmara M., Datta P., Zhang Z., Alnemri E.S. The PYRIN-CARD protein ASC is an activating adaptor for caspase-1. J. Biol. Chem. 277:2002;21119-21122.
30. Stehlik C., Krajewska M., Welsh K., Krajewski S., Godzik A., Reed J.C. The PAAD/PYRIN-only protein POP1/ASC2 is a modulator of ASC-mediated NF-κB and pro-Caspase-1 regulation. Biochem. J. 373:2003;101-113.
31. Martinon F., Burns K., Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-β Mol. Cell. 10:2002;417-426.
32. Hoffman H.M., Mueller J.L., Broide D.H., Wanderer A.A., Kolodner R.D. Mutation of a new gene encoding a putative PYRIN-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nature Genet. 29:2001;301-305.
33. Aganna E., Martinon F., Hawkins P.N., Ross J.B., Swan D.C., Booth D.R., et al. Association of mutations in the NALP3/CIAS1/PYPAF1 gene with a broad phenotype including recurrent fever, cold sensitivity, sensorineural deafness, and AA amyloidosis. Arthritis Rheum. 46:2002;2445-2452.
34. Manji G.A., Wang L., Geddes B.J., Brown M., Merriam S., Al-Garawi A., et al. PYPAF1, a PYRIN-containing Apaf1-like protein that assembles with ASC and regulates activation of NF-κB. J. Biol. Chem. 277:2002;11570-11575.
35. Wang L., Manji G.A., Grenier J.M., Al-Garawi A., Merriam S., Lora J.M., et al. PYPAF7, a novel PYRIN-containing Apaf1-like protein that regulates activation of NF-κB and caspase-1-dependent cytokine processing. J. Biol. Chem. 277:2002;29874-29880.
36. Fiorentino L., Stehlik C., Oliveira V., Ariza M.E., Godzik A., Reed J.C. A novel PAAD-containing protein that modulates NF-κB induction by cytokines tumor necrosis factor-α and interleukin-1β J. Biol. Chem. 277:2002;35333-35340.
37. Harton J.A., Linhoff M.W., Zhang J., Ting J.P. Cutting edge: CATERPILLER: a large family of mammalian genes containing CARD, PYRIN, nucleotide-binding, and leucine-rich repeat domains. J. Immunol. 169:2002;4088-4093.
38. Grenier J.M., Wang L., Manji G.A., Huang W.J., Al-Garawi A., Kelly R., et al. Functional screening of five PYPAF family members identifies PYPAF5 as a novel regulator of NF-κB and Caspase-1. FEBS Letters. 530:2002;73-78.
39. Xie J.P., Briggs J.A., Briggs R.C. MNDA dimerizes through a complex motif involving an N-terminal basic region. FEBS Letters. 408:1997;151-155.
40. Hlaing T., Guo R.F., Dilley K.A., Loussia J.M., Morrish T.A., Shi M.M., et al. Molecular cloning and characterization of DEFCAP-L and -S, two isoforms of a novel member of the mammalian Ced-4 family of apoptosis proteins. J. Biol. Chem. 276:2001;9230-9238.
41. Masumoto J., Taniguchi S., Ayukawa K., Sarvotham H., Kishino T., Niikawa N., et al. Caspy, a zebrafish caspase, activated by ASC oligomerization is required for pharyngeal arch development. J. Biol. Chem. 278:2003;4268-4276.
42. Holm L., Sander C. Protein structure comparison by alignment of distance matrices. J. Mol. Biol. 233:1993;123-136.
43. Bateman A., Birney E., Cerruti L., Durbin R., Etwiller L., Eddy S.R., et al. The Pfam protein families database. Nucl. Acids Res. 30:2002;276-280.
44. Kaufmann M., Bozic D., Briand C., Bodmer J., Zerbe O., Kohl A., et al. Identification of a basic surface area of the FADD death effector domain critical for apoptotic signaling. FEBS Letters. 527:2002;250-254.
45. Weber C.H., Vincenz C. A docking model of key components of the DISC complex: death domain superfamily interactins redefined. FEBS Letters. 492:2001;171-176.
46. 2, a self contained protein interaction domain involved in apoptosis and inflammation. J. Biomol. NMR. 23:2002;151-152.
47. 1 decoupling in two-diemsnional NMR spectroscopy. J. Magn. Reson. 59:1984;178-185.
48. Bartels C., Xia T., Güntert P., Billeter M., Wüthrich K. The program XEASY for computer-supported NMR spectral analysis. J. Biomol. NMR. 5:1995;1-10.
49. Szyperski T., Güntert P., Otting G., Wüthrich K. Determination of scalar coupling constants by inverse Fourier transformation of in-phase multiplets. J. Magn. Reson. 99:1992;552-560.
50. Güntert P., Mumenthaler C., Wüthrich K. Torsion angle dynamics for NMR structure calculation with the new program DYANA. J. Mol. Biol. 273:1997;283-298.
51. Luginbühl P., Güntert P., Billeter M., Wüthrich K. The new program OPAL for molecular dynamics simulations and energy refinements of biological macromolecules. J. Biomol. NMR. 8:1996;136-146.
52. Laskowski R.A., Rullmann J.A.C., MacArthur M.W., Kaptein R., Thornton J.M. AQUA and ROCHECK-NMR: programs for checking the quality of protein structures solved by NMR. J. Biomol. NMR. 8:1996;477-486.
53. Koradi R., Billeter M., Wüthrich K. MOLMOL: a program for display and analysis of macromolecular structures. J. Mol. Graph. 14:1996;51-55.
54. Sevilla-Sierra P., Otting G., Wüthrich K. Determination of the nuclear magnetic resonance structure of the DNA-binding domain of the P22 c2 repressor(1-76) in solution and comparison with the DNA-binding domain of the 434 repressor. J. Mol. Biol. 235:1994;1003-1020.